tirzepatide vulva Ozempic (semaglutide) and vaginal health GLP-1 Medications for Weight Loss:

However, 7.2 mg introduces a side effect that doesnt exist at standard doses: dysesthesia abnormal skin sensations described as burning, hypersensitivity, or pain

The result is a gradual slide into mild dehydration that manifests as headaches, fatigue, persistent tiredness , constipation, dizziness, and poor concentration

Table of Contents Can Weight Loss Injections Cause Headaches

Gastrointestinal side effects may be compounded

In SURMOUNT-1 the 15 mg arm averaged 22.5% body weight loss at 72 weeks, only modestly higher than the 10 mg arm at 21.4%

The development of tirzepatide represents a significant advance beyond selective GLP-1 receptor agonists such as liraglutide, dulaglutide, and semaglutide, which have been the cornerstone of incretin-based therapy over the past decade (Fras et al